CSF biomarkers in HIV dementia: Through a glass darkly

Neurology

Volumn 73, Issue 23, 2009, Pages 1942-1944

  McGuire, Dawn ^a  

^a Western NeuroAIDS Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; MONOKINE; NEUROTOXIN; PLACEBO; SELEGILINE; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DISEASE COURSE; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INFLAMMATION; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 73349088134     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181c51a92     Document Type: Editorial

References (14)

1. Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007;27:86-92.
2. McArthur JC, McDermott MD, McClernon D, et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 2004;61:1687-1696.
3. Paul R, Cohen R, Navia B, Tashima K. Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neu-rosci Biobehav Rev 2002;26:353-359.
4. Cloak CC, Chang L, Ernst T. Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. J Neuroimmunol 2004;157:147-152.
5. Ragin AB, Wu Y, Storey P, Cohen BA, Edelman RR, Epstein LG. Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol 2005;11:292-298.
6. Persidsky Y, Gendelman HE. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 2003;74:691-701.
7. Formichi P, Battisti C, Radi E, Federico A. Cerebrospi-nal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease J Cell Physiol 2006; 208:39-46.
8. Gray F, Adle-Biassette H, Cretien F, et al. Neuropathology and neurodegeneration in human immunodeficiency virus infection: pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001;20:146-155.
9. Schifitto G, Yiannoutsos CT, Ernst T, et al. Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology 2009;73:1975-1981.
10. Clifford DB, Fagan AM, Holtzman DM, et al. CSF bi-omarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 2009;73:1982-1987.
11. Schifitto G, Zhang J, Evans SR, et al. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 2007;69:1314-1321. (Pubitemid 47482445)
12. Pulliam L. HIV regulation of amyloid beta production. J Neuroimmune Pharmacol 2009;4:213-217.
13. Luo X, Carlson KA, Wojna V, et al. Macrophage pro-teomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 2003;60:1931-1937.
14. Laspiur JP, Anderson ER, Ciborowski P, et al. CF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol 2007;192:157-170.